Recruiting

Remote Symptom Monitoring

Sponsor:

Carevive Systems, Inc.

Code:

NCT05974150

Conditions

Breast Cancer

Lung Cancer

Multiple Myeloma

Ovarian Cancer

Acute Myelogenous Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Web based survey

Study Details

Brief summary:

The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment.

Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.

Conditions

Breast Cancer

Lung Cancer

Multiple Myeloma

Ovarian Cancer

Acute Myelogenous Leukemia

Study ID

NCT05974150

Start date

Jul 19, 2023

Status verified date

Feb, 2026

Completion date

Dec 31, 2026

Anticipated

Primary completion date

Nov 5, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • All participants must be 18 years of age or older.
  • Subjects may be any stage and anywhere in the treatment continuum.
  • Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma.
  • Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
  • All participants must be able to understand English.

Exclusion Criteria:

  • Any patient who cannot understand written or spoken English.
  • Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
  • Any patient on a treatment clinical trial.
  • Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

Study Design

Enrollment

25 participants

Anticipated

Interventions and Outcome Measures

Interventions

Web based survey

online weekly survey

Primary outcome measure

  • Create Data Set [ Time Frame: 1 year ]

Central Contacts and Locations

Central contacts

JULIE SCOTT, MSN

8778423210Julie.Scott@Carevive.com

Locations

Northshore University Health System

Recruiting

Evanston, Illinois, United States, 31024

Contacts

Michele Britto

MBritto@northshore.org

Principal Investigator:

Nicklas Pfanzelter

Cleveland Clinic Mercy Hospital

Recruiting

Canton, Ohio, United States, 44708

Contacts

Janet Muckley

MUCKLEJ@ccf.org

Principal Investigator:

Mitchell Haut, MD

University Hospitals Seidman Cancer Center

Recruiting

Cleveland, Ohio, United States, 44106

Contacts

Jill Severino-Powell, MSN

Jill.Severino-Powell@UHhospitals.org

Principal Investigator:

Alberto Montero, MD

Tri-County Hematology & Oncology Associates, Inc.

Recruiting

Massillon, Ohio, United States, 44646

Contacts

Janet Muckley

MUCKLEJ@ccf.org

Principal Investigator:

Nagaprasad Nagajothi, MD

More Information

Sponsor

Carevive Systems, Inc.

Last update posted

Feb 23, 2026

Last verified

Feb, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Carevive Systems, Inc. on 2026-02-23.